Michael Giffin currently serves as the Director of Analytical Development at ElevateBio, having previously held the position of Cell Therapies Lead in Analytical Development at Beam Therapeutics, where responsibilities included leading analytical teams in method development for gene-edited cell therapies and authoring INDs. Prior to that, Michael was Associate Director of Analytical Development at Amgen, focusing on analytics strategies for cell therapy products and risk-based frameworks. Michael's earlier career included significant contributions at The Scripps Research Institute and the University of Colorado Boulder, with a Ph.D. in Biochemistry from the University of Colorado Boulder and a BS in Molecular and Cellular Biology from Texas A&M University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices